Skip to main content
Sumitomo Pharma Co., Ltd. logo

Sumitomo Pharma Co., Ltd. — Investor Relations & Filings

Ticker · 4506 ISIN · JP3495000006 LEI · 529900D60UKVYLJ2OJ79 T Manufacturing
Open in API
Filings indexed 93 across all filing types
Latest filing 2026-05-22 Share Issue/Capital Cha…
Country JP Japan
Listing T 4506

About Sumitomo Pharma Co., Ltd.

https://www.sumitomo-pharma.com/

Sumitomo Pharma Co., Ltd. is a research and development-driven pharmaceutical company focused on creating innovative pharmaceuticals and healthcare solutions. The company's primary therapeutic areas are Psychiatry & Neurology and Oncology, with additional activities in diabetes, rare diseases, and women's health. A key aspect of its R&D strategy is the integration of established expertise in small molecule drug discovery with pioneering modalities such as regenerative medicine and cell therapy. The company's mission is to translate scientific innovation into real-world solutions to contribute to the betterment of healthcare and fuller lives for people worldwide, with a strategic business focus on Japan and the United States.

Recent filings

Filing Released Lang Actions
第三者割当増資の結果(不実施)に関するお知らせ
Share Issue/Capital Change Classification · 90% confidence The document is a corporate press release from Sumitomo Pharma announcing the results of a previously approved third-party allotment of new shares (i.e., no subscriptions were received and the share issuance will not be implemented). It pertains directly to a change in share capital through a planned (but ultimately aborted) share issuance. This falls squarely under “Share Issue/Capital Change,” code SHA.
2026-05-22 Japanese
訂正有価証券届出書（参照方式）
Share Issue/Capital Change Classification · 15% confidence The document is a Japanese “有価証券届出書” (securities registration statement) filed with the Kanto Finance Bureau regarding a third‐party allotment capital increase (new share issuance, overallotment, domestic and overseas offering). It contains detailed terms of the share issuance, amounts, conditions, uses of proceeds and related special matters. This is not a simple publication announcement or regulatory fallback; it is the actual new share issue prospectus. Therefore, it falls under Share Issue/Capital Change (SHA).
2026-05-13 Japanese
訂正有価証券届出書（参照方式）
Share Issue/Capital Change Classification · 88% confidence The document is a Japanese securities registration statement (“有価証券届出書”) for a third-party allotment of new shares, detailing the type and number of shares issued, offering amounts, use of proceeds, issuance conditions, over-allotment options, and related procedures under the Financial Instruments and Exchange Act. This is clearly an announcement and detailed disclosure of a new share issue (capital change) rather than an annual report, earnings release, or management presentation. Therefore, it falls under the Share Issue/Capital Change category (SHA).
2026-04-27 Japanese
訂正臨時報告書
Share Issue/Capital Change Classification · 90% confidence The document is a Japanese Financial Instruments and Exchange Act “臨時報告書” (timely disclosure) filed April 8, 2026, detailing a board resolution to issue 29,500,000 new common shares overseas (Rule 144A) and related domestic offerings, pricing, use of proceeds, underwriting, listing plans, etc. This is a specific announcement of a new share issuance/capital change rather than an earnings release, annual or interim report, or management presentation. It matches the “Share Issue/Capital Change” category.
2026-04-27 Japanese
訂正発行登録書
Share Issue/Capital Change Classification · 80% confidence The document is a "訂正発行登録書" (corrected issuance registration statement) filed with the Kanto Finance Bureau, detailing the registered share issuance (株式発行登録) including issue amount, registration number, and validity. This is not a general annual or quarterly report but a legal notice of share issuance registration. Therefore it falls under Share Issue/Capital Change (SHA).
2026-04-20 Japanese
訂正有価証券届出書（参照方式）
Share Issue/Capital Change Classification · 88% confidence The document is a Japanese securities registration statement (有価証券届出書) describing in detail a third-party allotment equity issuance (募集要項, 株式募集の方法・条件, use of proceeds, etc.). It is not an AGM material, annual report, earnings release, or other standard report. Instead, it is a formal share issue prospectus announcing new share issuance and capital change activity. Under our taxonomy, this best fits Share Issue/Capital Change (SHA).
2026-04-20 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.